{
    "2018-08-30": [
        [
            {
                "time": "2018-08-29",
                "original_text": "Glaukos Stock Rose 40.3% on August 29",
                "features": {
                    "keywords": [
                        "Glaukos",
                        "Stock",
                        "Rose",
                        "40.3%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Estimates and Recommendations for Novartis in August",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Estimates",
                        "Recommendations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Novartisâ€™s Key Developments in August",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Key",
                        "Developments"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Should You Be Tempted To Buy Novartis AG (VTX:NOVN) Because Of Its PE Ratio?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "PE Ratio",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Mass. antibiotics developers say the field is getting slowly better",
                "features": {
                    "keywords": [
                        "antibiotics",
                        "developers",
                        "better"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}